Guggenheim Capital’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.78M | Sell |
14,101
-83,700
| -86% | -$16.1M | 0.02% | 606 |
|
|
2025
Q4 | $18M | Buy |
97,801
+2,269
| +2% | +$398K | 0.13% | 149 |
|
|
2025
Q3 | $14.7M | Sell |
95,532
-1,648
| -2% | -$249K | 0.11% | 193 |
|
|
2025
Q2 | $13.6M | Buy |
97,180
+15,550
| +19% | +$2.18M | 0.11% | 194 |
|
|
2025
Q1 | $12M | Sell |
81,630
-18,127
| -18% | -$2.62M | 0.11% | 195 |
|
|
2024
Q4 | $13.1M | Sell |
99,757
-3,918
| -4% | -$549K | 0.11% | 190 |
|
|
2024
Q3 | $16.2M | Sell |
103,675
-6,015
| -5% | -$971K | 0.11% | 180 |
|
|
2024
Q2 | $17.1M | Buy |
109,690
+1,003
| +0.9% | +$151K | 0.12% | 162 |
|
|
2024
Q1 | $14.7M | Sell |
108,687
-2,720
| -2% | -$360K | 0.1% | 198 |
|
|
2023
Q4 | $15M | Buy |
111,407
+3,029
| +3% | +$394K | 0.11% | 188 |
|
|
2023
Q3 | $14.7M | Buy |
108,378
+10,043
| +10% | +$1.37M | 0.13% | 177 |
|
|
2023
Q2 | $14.1M | Sell |
98,335
-3,357
| -3% | -$494K | 0.11% | 196 |
|
|
2023
Q1 | $14.1M | Buy |
101,692
+2,913
| +3% | +$392K | 0.12% | 188 |
|
|
2022
Q4 | $13.4M | Sell |
98,779
-16,168
| -14% | -$2.03M | 0.12% | 202 |
|
|
2022
Q3 | $12.6M | Sell |
114,947
-4,068
| -3% | -$516K | 0.12% | 208 |
|
|
2022
Q2 | $15.7M | Sell |
119,015
-14,911
| -11% | -$1.96M | 0.12% | 193 |
|
|
2022
Q1 | $17.8M | Sell |
133,926
-5,378
| -4% | -$645K | 0.11% | 220 |
|
|
2021
Q4 | $16.2M | Sell |
139,304
-33,582
| -19% | -$3.95M | 0.08% | 258 |
|
|
2021
Q3 | $20.8M | Buy |
172,886
+149,298
| +633% | +$17.4M | 0.12% | 170 |
|
|
2021
Q2 | $2.83M | Buy |
23,588
+863
| +4% | +$94.7K | 0.02% | 917 |
|
|
2021
Q1 | $2.26M | Buy |
22,725
+3,923
| +21% | +$394K | 0.01% | 961 |
|
|
2020
Q4 | $1.88M | Buy |
18,802
+8,246
| +78% | +$873K | 0.01% | 998 |
|
|
2020
Q3 | $1.16M | Sell |
10,556
-2,863
| -21% | -$318K | 0.01% | 1148 |
|
|
2020
Q2 | $1.42M | Buy |
13,419
+2,606
| +24% | +$269K | 0.01% | 1037 |
|
|
2020
Q1 | $965K | Sell |
10,813
-2,031
| -16% | -$191K | 0.01% | 1106 |
|
|
2019
Q4 | $1.28M | Buy |
12,844
+185
| +1% | +$17.4K | 0.01% | 1238 |
|
|
2019
Q3 | $1.13M | Sell |
12,659
-6,459
| -34% | -$560K | 0.01% | 1270 |
|
|
2019
Q2 | $1.58M | Sell |
19,118
-6,254
| -25% | -$490K | 0.01% | 1150 |
|
|
2019
Q1 | $2.05M | Buy |
25,372
+3,934
| +18% | +$310K | 0.02% | 1058 |
|
|
2018
Q4 | $1.63M | Sell |
21,438
-8,438
| -28% | -$659K | 0.01% | 1145 |
|
|
2018
Q3 | $2.36M | Buy |
29,876
+305
| +1% | +$23.1K | 0.02% | 1143 |
|
|
2018
Q2 | $2.08M | Buy |
29,571
+226
| +0.8% | +$16.3K | 0.01% | 1234 |
|
|
2018
Q1 | $2.05M | Sell |
29,345
-45,515
| -61% | -$3.15M | 0.01% | 1617 |
|
|
2017
Q4 | $5.2M | Sell |
74,860
-12,789
| -15% | -$862K | 0.01% | 1016 |
|
|
2017
Q3 | $5.94M | Buy |
87,649
+37,905
| +76% | +$2.39M | 0.01% | 961 |
|
|
2017
Q2 | $3.39M | Sell |
49,744
-44,524
| -47% | -$2.91M | 0.01% | 1242 |
|
|
2017
Q1 | $5.87M | Buy |
94,268
+44,694
| +90% | +$2.6M | 0.02% | 933 |
|
|
2016
Q4 | $2.71M | Sell |
49,574
-43,004
| -46% | -$2.44M | 0.01% | 1443 |
|
|
2016
Q3 | $6.08M | Sell |
92,578
-5,322
| -5% | -$348K | 0.02% | 906 |
|
|
2016
Q2 | $5.91M | Buy |
97,900
+2,665
| +3% | +$155K | 0.02% | 903 |
|
|
2016
Q1 | $5.36M | Sell |
95,235
-18,303
| -16% | -$1.1M | 0.02% | 956 |
|
|
2015
Q4 | $7.71M | Sell |
113,538
-63,841
| -36% | -$4.19M | 0.02% | 847 |
|
|
2015
Q3 | $11.3M | Sell |
177,379
-150,661
| -46% | -$9.91M | 0.03% | 706 |
|
|
2015
Q2 | $20.9M | Sell |
328,040
-86,957
| -21% | -$5.95M | 0.05% | 606 |
|
|
2015
Q1 | $28.4M | Sell |
414,997
-25,737
| -6% | -$1.79M | 0.07% | 537 |
|
|
2014
Q4 | $31M | Sell |
440,734
-100,803
| -19% | -$7.22M | 0.08% | 467 |
|
|
2014
Q3 | $38.7M | Buy |
541,537
+95,785
| +21% | +$7.01M | 0.09% | 336 |
|
|
2014
Q2 | $33.1M | Buy |
445,752
+55,521
| +14% | +$4.01M | 0.08% | 416 |
|
|
2014
Q1 | $25.3M | Sell |
390,231
-140,388
| -26% | -$9.07M | 0.07% | 494 |
|
|
2013
Q4 | $31.5M | Buy |
530,619
+70,005
| +15% | +$3.8M | 0.1% | 309 |
|
|
2013
Q3 | $23.9M | Buy |
460,614
+41,323
| +10% | +$2.08M | 0.09% | 338 |
|
|
2013
Q2 | $19.8M | Buy |
+419,291
| New | +$21.4M | 0.08% | 339 |
|
Other funds holding AZN
IA
VCM
VAM
Guggenheim Capital's AZN Position: Q1 2026 in Review
Guggenheim Capital reduced its AstraZeneca (AZN) stake by 86% in Q1 2026, selling an estimated $16.1M and leaving 14,101 shares worth $2.78M. The position accounts for 0.02% of the portfolio, ranked #606.
Guggenheim Capital first reported a position in AZN in Q2 2013 and has held it in 52 quarters since. The position peaked at $38.7M in Q3 2014. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.
- Guggenheim Capital held 14,101 shares of AstraZeneca worth $2.78M as of Q1 2026.
- Guggenheim Capital sold 83,700 AstraZeneca shares in Q1 2026, an estimated $16.1M.
- AstraZeneca made up 0.02% of Guggenheim Capital's portfolio in Q1 2026, its #606 holding.
- Guggenheim Capital first reported a position in AstraZeneca in Q2 2013 and has held it in 52 quarters since.
- Guggenheim Capital's AstraZeneca position peaked at $38.7M in Q3 2014.
- 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.
Based on Guggenheim Capital's 13F filing for Q1 2026, filed 15 May 2026.